Investment firms Therese Liechtenstein joined 4BIO as Investment Director Jupiter Bioventures launches with $70M fund dedicated to biotech startups developing cancer therapeutics or advancing adjacent programs based on cancer biology Media Elizabeth Cairns to join Endpoints as Senior Biopharma Reporter Olivia Freitt has been appointed Editor at European Pharmaceutical Manufacturer Carrie Haslam has been appointed […]
By Richard Staines, Optimum Strategic Communications The re-election of Donald Trump as President of the Unites States represents a seismic shift in the U.S. political system, with huge ramifications for all policy areas including healthcare. But, at the time of writing, the identity of the next Secretary of the Department of Health and Human Services […]
LONDON, Oct. 8, 2024 /PRNewswire/ — Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 16th Annual Healthcare Investor Conference on Thursday 10 October, 2024 at The Kings Fund, London. This year, as markets begin to bounce back after a lacklustre period, a prestigious line-up of industry experts will look to growth, identifying which therapies will attract investor […]
Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine Vicebio Ltd, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, on Monday announced a $100 million Series B financing led by TCGX with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio, and participation from UniQuest and founding investor Medicxi. London-based Vicebio said funding […]
